Hyderabad: A startup incubated at the University of Hyderabad (UoH) successfully tested a new treatment for chronic liver ...

ASPIRE-BioNEST at UoH and Tulsi Therapeutics announce world’s first successful pre-clinical trial of Stem Cell–Exosome ...

HYDERABAD: A Hyderabad-based startup, Tulsi Therapeutics, has demonstrated the complete reversal of chronic liver failure in ...

Tulsi Therapeutics achieves groundbreaking success in animal trial for liver disease treatment, paving way for human trials.

Tulsi Therapeutics achieves groundbreaking success with novel stem cell–exosome therapy for chronic liver failure at ...

Tulsi Therapeutics, a biotech startup from Hyderabad, has reversed chronic liver failure in animal trials using Tulsi-28X, a ...

In a landmark moment for India’s biotechnology sector, Hyderabad-based biotech startup Tulsi Therapeutics, which focused on regenerative medicine using stem cells and exosomes, and ASPIRE-BioNEST, ...

Don't get caught out if you're heading to the U.K., those Brits have a ton of different words for some common foods, and you ...

Hyderabad has made a remarkable breakthrough in biotechnology. Tulsi Therapeutics, a startup nurtured at ASPIRE-BioNEST at ...